Sodium-Glocuse Cotransporter-2 Inhibitor Decreases the Risk of Heart Failure Hospitalization & Regardless of Left Ventricular Ejection Fraction

Authors

Hussein A. Noureldine, HCA HealthcareFollow
Thais Schwartz, HCA HealthcareFollow
Qusai Alqudah, HCA HealthcareFollow
Maryam Alhousseini
Ann T. Tong

Files

Division

North Florida

Hospital

HCA Florida North Florida Hospital

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2025

Keywords

Sodium-Glucose Cotransporter-2, Heart Failure

Disciplines

Cardiovascular Diseases | Internal Medicine | Medicine and Health Sciences

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

Noureldine, Hussein A.; Schwartz, Thais; Alqudah, Qusai; Alhousseini, Maryam; and Tong, Ann T., "Sodium-Glocuse Cotransporter-2 Inhibitor Decreases the Risk of Heart Failure Hospitalization & Regardless of Left Ventricular Ejection Fraction" (2025). North Florida Division GME Research Day 2025. 24.
https://scholarlycommons.hcahealthcare.com/northflorida2025/24